Consistent with the IHI’s policy, faculty for this program are expected to disclose at the beginning of their presentation(s) any economic or other personal interests that create, or may be perceived as creating, a conflict related to the material discussed. The intent of this disclosure is not to prevent a speaker with a significant financial or other relationship from making a presentation, but rather to provide participants with information on which they can make their own judgments.

Unless otherwise noted below, each presenter provided full disclosure information, does not intend to discuss an unapproved/investigative use of a commercial product/device, and has no significant financial relationship(s) to disclose. If unapproved uses of products are discussed, presenters are expected to disclose this to participants.

Frances A. Griffin, RRT, MPA, is a Director at IHI, working in patient safety, reliability and other improvement projects. Prior to joining IHI, Ms. Griffin worked at two hospital systems in New Jersey, as a director overseeing quality, case management and other related departments. Ms. Griffin is a Registered Respiratory Therapist and holds a Master’s Degree in Public Administration.

Gregory Maynard, MD, MSc, is a Clinical Professor of Medicine and Chief of the division of Hospital Medicine at the University of California, San Diego. He is active on both a local and national level (often via the Society of Hospital Medicine) in many efforts to improve the quality and safety of the care delivered to inpatients. Dr. Maynard’s special interests include optimizing prevention and management of venous thromboembolism (VTE), improving glycemic control and reducing hypoglycemia in the hospital, and transitions of care.  Dr. Maynard’s research interests parallel his QI efforts, and he is principal investigator or otherwise involved in several funded research efforts. He acts as a leader, mentor, and investigator in three national collaboratives to improve VTE prevention. He is a mentor / investigator for Project BOOST, an SHM initiative to improve transitions in care, and is also a mentor / investigator for the SHM Glycemic Control collaborative.  Dr. Maynard was recently recognized as one of ACP Hospitalist's top hospitalists, and has been recognized nationally for his work in Quality Improvement by the Society of Hospital Medicine, and the National Association of Public Hospitals.